Semaglutide mimics GLP-1, Tirzepatide targets GLP-1 and GIP, and Retatrutide is being studied for its effects on GLP-1, GIP, and glucagon receptors to support appetite control and metabolic function
Stopping the medication may resolve neurochemical sexual side effects but reintroduce the psychological barriers to desire that existed before treatment
Robert Appel recommends a comprehensive approach to targeting the root causes of GLP-1 oral side effects: Strategic Hydration : Drink water consistently throughout the day, not just at meal times, and avoid sugary or acidic beverages that can further irritate dry oral tissues
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for type 2 diabetes management and chronic weight management
When switching, your doctor will start you on a low dose of semaglutide GLP-1
Were here to provide answers to the most frequently asked questions about tirzepatide, so you can make an informed decision about starting treatment